The analysis of microRNA expression profiling for coronary artery disease

Cardiology (Switzerland)

Volumn 127, Issue 1, 2013, Pages 62-69

  Li, Kefei ^a   Zhang, Tao ^a   Fan, Huimin ^a   Li, Qinchuan ^a   Ito, Wulf ^b   Torzewski, Jan ^b   Guo, Jianhua ^a   Liu, Zhongmin ^a  

^a Key Laboratory of Arrhythmias of Ministry of Education   (China)

^b Cardiovascular Center Oberallgau Kempten   (Germany)

Author keywords

Coronary artery disease; Differentially expressed miRNA; Interaction network; microRNA; miRNA 526b; Pathway analysis; Target gene; Toll like receptor 4

Indexed keywords

MICRORNA; TOLL LIKE RECEPTOR 4; VASCULOTROPIN;

ACUTE CORONARY SYNDROME; ALGORITHM; ARTICLE; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY DISEASE; DATA BASE; GENE EXPRESSION PROFILING; HEART INFARCTION; PHENOTYPE; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANK SUM TEST; RNA ANALYSIS; SIGNAL TRANSDUCTION; STUDENT T TEST; CLINICAL ARTICLE; CONTROLLED STUDY; GENE; GENE INTERACTION; GENE TARGETING; GEOMETRY; HUMAN; MICROARRAY ANALYSIS; UPREGULATION;

CASE-CONTROL STUDIES; CORONARY ARTERY DISEASE; FEMALE; HUMANS; MALE; MICROARRAY ANALYSIS; MICRORNAS; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 4; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84890914721     PISSN: 00086312     EISSN: 14219751     Source Type: Journal    
DOI: 10.1159/000354872     Document Type: Article

References (28)

1. Libby P, Ridker PM, Hansson GK: Progress and challenges in translating the biology of atherosclerosis. Nature 2011; 473: 317-325.
2. Bartel DP: MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004; 116: 281-297.
3. Wang J, Yu G: Study on microRNA and Chinese medicine syndromes of coronary artery disease (in Chinese). Zhongguo Zhong Xi Yi Jie He Za Zhi 2012; 32: 1562-1565.
4. van Rooij E, Sutherland LB, Liu N, Williams AH, McAnally J, Gerard RD, et al: A signature pattern of stress-responsive microRNAs that can evoke cardiac hypertrophy and heart failure. Proc Natl Acad Sci USA 2006; 103: 18255-18260.
5. Fichtlscherer S, De Rosa S, Fox H, Schwietz T, Fischer A, Liebetrau C, et al: Circulating microRNAs in patients with coronary artery disease. Circ Res 2010; 107: 677-684.
6. Takahashi Y, Satoh M, Minami Y, Tabuchi T, Itoh T, Nakamura M: Expression of miR-146a/b is associated with the Toll-like receptor 4 signal in coronary artery disease: effect of renin-angiotensin system blockade and statins on miRNA-146a/b and Toll-like receptor 4 levels. Clin Sci (Lond) 2010; 119: 395-405.
7. Minami Y, Satoh M, Maesawa C, Takahashi Y, Tabuchi T, Itoh T, et al: Effect of atorvastatin on microRNA 221/222 expression in endothelial progenitor cells obtained from patients with coronary artery disease. Eur J Clin Invest 2009; 39: 359-367.
8. Iribarren C, Phelps BH, Darbinian JA, Mc-Cluskey ER, Quesenberry CP, Hytopoulos E, et al: Circulating angiopoietins-1 and -2, angiopoietin receptor Tie-2 and vascular endothelial growth factor-A as biomarkers of acute myocardial infarction: a prospective nested case-control study. BMC Cardiovasc Disord 2011; 11: 31.
9. Urbich C, Kuehbacher A, Dimmeler S: Role of microRNAs in vascular diseases, inflammation, and angiogenesis. Cardiovasc Res 2008; 79: 581-588.
10. van Rooij E, Marshall WS, Olson EN: Toward microRNA-based therapeutics for heart disease: the sense in antisense. Circ Res 2008; 103: 919-928.
11. Small EM, Olson EN: Pervasive roles of microRNAs in cardiovascular biology. Nature 2011; 469: 336-342.
12. Sondermeijer BM, Bakker A, Halliani A, de Ronde MW, Marquart AA, Tijsen AJ, et al: Platelets in patients with premature coronary artery disease exhibit upregulation of miRNA340 and miRNA624. PLoS One 2011; 6:e25946.
13. Troyanskaya O, Cantor M, Sherlock G, Brown P, Hastie T, Tibshirani R, et al: Missing value estimation methods for DNA microarrays. Bioinformatics 2001; 17: 520-525.
14. Wang X, Li A, Jiang Z, Feng H: Missing value estimation for DNA microarray gene expression data by Support Vector Regression imputation and orthogonal coding scheme. BMC Bioinformatics 2006; 7: 32.
15. Liu CG, Calin GA, Meloon B, Gamliel N, Sevignani C, Ferracin M, et al: An oligonucleotide microchip for genome-wide microRNA profiling in human and mouse tissues. Proc Natl Acad Sci USA 2004; 101: 9740-9744.
16. Reiner-Benaim A: FDR control by the BH procedure for two-sided correlated tests with implications to gene expression data analysis. Biom J 2007; 49: 107-126.
17. Tusher VG, Tibshirani R, Chu G: Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci USA 2001; 98: 5116-5121.
18. Murray CJ, Lopez AD: Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study. Lancet 1997; 349: 1436-1442.
19. Harismendy O, Notani D, Song X, Rahim NG, Tanasa B, Heintzman N, et al: 9p21 DNA variants associated with coronary artery disease impair interferon-γ signalling response. Nature 2011; 470: 264-268.
20. Damani SB, Topol EJ: Emerging genomic applications in coronary artery disease. JACC Cardiovasc Interv 2011; 4: 473-482.
21. Konopka A, Janas J, Piotrowski W, Stepinska J: Concentration of vascular endothelial growth factor in patients with acute coronary syndrome. Cytokine 2013; 61: 664-669.
22. Forsythe JA, Jiang BH, Iyer NV, Agani F, Leung SW, Koos RD, et al: Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Mol Cell Biol 1996; 16: 4604-4613.
23. Blann AD, Belgore FM, McCollum CN, Silverman S, Lip PL, Lip GY: Vascular endothelial growth factor and its receptor, Flt-1, in the plasma of patients with coronary or peripheral atherosclerosis, or type II diabetes. Clin Sci (Lond) 2002; 102: 187-194.
24. Kucukardali Y, Aydogdu S, Ozmen N, Yonem A, Solmazgul E, Ozyurt M, et al: The relationship between severity of coronary artery disease and plasma level of vascular endothelial growth factor. Cardiovasc Revasc Med 2008; 9: 66-70.
25. Alber HF, Frick M, Dulak J, Dorler J, Zwick RH, Dichtl W, et al: Vascular endothelial growth factor (VEGF) plasma concentrations in coronary artery disease. Heart 2005; 91: 365-366.
26. Miyake K: Innate immune sensing of pathogens and danger signals by cell surface Tolllike receptors. Semin Immunol 2007; 19: 3-10.
27. Botero TM, Shelburne CE, Holland GR, Hanks CT, Nor JE: TLR4 mediates LPS-induced VEGF expression in odontoblasts. J Endod 2006; 32: 951-955.
28. Pei Z, Lin D, Song X, Li H, Yao H: TLR4 signaling promotes the expression of VEGF and TGFβ 1 in human prostate epithelial PC3 cells induced by lipopolysaccharide. Cell Immunol 2008; 254: 20-27.